Lloyd J. Old
Immunology · 2001–2012
A researcher in the Science corpus: 15 papers; trusts 4 researchers and is trusted by 33 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 133 citations into it; #88 of 2,160 by trust here, #61 by citations
- Oncology — 86 citations into it; #61 of 1,698 by trust here, #62 by citations
Whom Lloyd J. Old trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Lloyd J. Old overall
- S. Grivennikov
- G. Dunn
- M. Smyth
- S. Formenti
- Robert Schreiber
- M. Egeblad
- F. Greten
- L. Zitvogel
- D. Mittal
- Michael S. Rooney
Papers from Lloyd J. Old's perspective
Ordered by how strongly the researchers Lloyd J. Old trusts endorse each paper. Same corpus, a different order for every researcher.
- Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells (Journal of Experimental Medicine)
- Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells (Journal of Experimental Medicine)
- Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells (Journal of Experimental Medicine)
- Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. (Advances in Immunology)
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates (Journal of Clinical Oncology)
- Integrative Genomics Viewer (Nature Biotechnology)
- Trastuzumab--mechanism of action and use in clinical practice. (New England Journal of Medicine)
- Coregulation of CD8+ T cell exhaustion during chronic viral infection by multiple inhibitory receptors (Nature Immunology)
- Restoring function in exhausted CD8 T cells during chronic viral infection (Nature)
- The B7 family revisited. (Annual Review of Immunology)
Their papers
- Cancer immunoediting: from immunosurveillance to tumor escape (2002) — 5,197 citations
- Cancer/testis antigens, gametogenesis and cancer (2005) — 1,613 citations
- CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens (2008) — 411 citations
- Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting (2012) — 1,252 citations
- Antibody therapy of cancer (2012) — 1,292 citations
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (2011) — 6,056 citations
- Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer (2010) — 830 citations
- Adaptive immunity maintains occult cancer in an equilibrium state (2007) — 1,413 citations
- Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (2005) — 2,404 citations
- The immunobiology of cancer immunosurveillance and immunoediting. (2004) — 2,941 citations
- The three Es of cancer immunoediting. (2004) — 2,997 citations
- The cancer/testis genes: review, standardization, and commentary. (2004) — 724 citations
- Cancer/testis antigens: an expanding family of targets for cancer immunotherapy (2002) — 893 citations
- The roles of IFNγ in protection against tumor development and cancer immunoediting (2002) — 769 citations
- IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity (2001) — 2,659 citations